These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3079371)
1. Hemoglobin solutions as blood substitutes: an overview. Bellelli A; Brunori M Ann Ital Med Int; 1986 Dec; 1(4):275-80. PubMed ID: 3079371 [No Abstract] [Full Text] [Related]
2. [Perftoran--blood substitute with oxygen transport function]. Golubev AM Biull Eksp Biol Med; 1998 May; 125(5):484-92. PubMed ID: 9644539 [No Abstract] [Full Text] [Related]
3. [Current aspects in red blood cell substitutes]. Wang Y; Pan J; Yu Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164 [TBL] [Abstract][Full Text] [Related]
5. Blood substitutes and oxygen therapeutics: an overview and current status. Jahr JS; Nesargi SB; Lewis K; Johnson C Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737 [TBL] [Abstract][Full Text] [Related]
6. Present trends in fluorocarbon-based blood substitutes. Riess JG Life Support Syst; 1984; 2(4):273-6. PubMed ID: 6527557 [No Abstract] [Full Text] [Related]
8. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes. Tao Z; Ghoroghchian PP Trends Biotechnol; 2014 Sep; 32(9):466-73. PubMed ID: 24929580 [TBL] [Abstract][Full Text] [Related]
9. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
10. Oxygen therapeutics--current concepts. Hill SE Can J Anaesth; 2001 Apr; 48(4 Suppl):S32-40. PubMed ID: 11336435 [TBL] [Abstract][Full Text] [Related]
11. Perfluorocarbons and haemoglobin solutions: will they ever reach clinical practice? Lamy M; Deby-Dupont G Acta Anaesthesiol Belg; 2003; 54(4):299-300. PubMed ID: 14719348 [No Abstract] [Full Text] [Related]